Authors: Kereiakes, DJ Fry, E Matthai, W Niederman, A Barr, L Brodie, B Zidar, J Casale, P Christy, G Moliterno, D Lengerich, R Broderick, T Shimshak, T Cohen, M

Citation: Dj. Kereiakes et al., Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first", J INVAS CAR, 12, 2000, pp. 1A-5A

Authors: Kereiakes, DJ McDonald, M Broderick, T Roth, EM Whang, DD Martin, LH Howard, WL Schneider, J Shimshak, T Abbottsmith, CW

Citation: Dj. Kereiakes et al., Platelet glycoprotein IIb/IIIa receptor blockers: An appropriate-use modelfor expediting care in acute coronary syndromes, AM HEART J, 139(2), 2000, pp. S53-S60

Authors: Kereiakes, DJ Broderick, TM Roth, EM Whang, D Shimshak, T Runyon, JP Hattemer, C Schneider, J Lacock, P Mueller, M Abbottsmith, CW

Citation: Dj. Kereiakes et al., Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention, AM J CARD, 84(4), 1999, pp. 391-395